Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Onyx is a research collective building a virtual immune system from longitudinal human immune data.
Curative provides employer-based health insurance plans and healthcare services.
Pila Energy develops innovative battery systems and software to provide energy security and energy management for homes and businesses.
Nome is the Operating System for Personalized Therapies™ — developing custom treatments for rare disease patients, families, and clinicians.
Hexium enriches isotopes for next-gen reactors using LLNL AVLIS including Lithium and Uranium
Parallel Bio develops tools that help in the discovery and development of immunotherapies.
Modern medication management at home.
Remedy Scientific is a pioneering environmental remediation technology firm
Modulo Bio is a biotech company that offers a platform for reprogramming neurocells to improve immunity.
General Galactic is a space tech startup developing advanced spacecraft and propulsion systems
Causal Labs is a research company building general causal intelligence
MIIST Therapeutics is a pulmonary drug delivery system and digital platform that enhances the science of inhaled drugs.
Macro Oceans develops technology to harness the restorative power of seaweed.
Granza Bio is a company that developing cancer therapies based on human body's immune system.
AKASA is an AI-powered automation company for revenue cycle management in healthcare.
Bedrock Materials is a startup company developing materials and manufacturing procedures for low-cost sodium-ion batteries.
Rubedo Life Sciences focuses on developing medicines that target the specific cells responsible for aging, known as pathologic cells.
Trace Genomics provides genetic insights into soil, helping farmers optimize their agricultural practices for better crop yield.
Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders.
Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.
Hyfé turns food waste into chemicals that maximize profits for food processors while allowing the world to make products without petroleum.
BioRender develops a science visualization platform for the pharmaceutical and life sciences industries.
AI-Powered digital experiences for the most vital points in care.
Checkerspot is a biology driven, molecule licensing company designing fats and oils through precision fermentation.
Refactor has invested in 60 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Refactor's top investment sectors include Biotechnology, Health Care, Artificial Intelligence (AI), Life Science, Pharmaceutical. The firm invests across 45 different industry categories.
Among tracked funding rounds, Curative received $150.0M in a Series B round. Refactor's total known invested capital is $1.2B.
Refactor's average investment size is $20.1M across its portfolio of 60 companies.
Recent Refactor portfolio additions include Onyx Bio, Curative, Pila Energy, Nome Bio, Hexium. These companies were founded in 2020 or later.